JP2007529544A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007529544A5 JP2007529544A5 JP2007504115A JP2007504115A JP2007529544A5 JP 2007529544 A5 JP2007529544 A5 JP 2007529544A5 JP 2007504115 A JP2007504115 A JP 2007504115A JP 2007504115 A JP2007504115 A JP 2007504115A JP 2007529544 A5 JP2007529544 A5 JP 2007529544A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- dosage form
- salt
- composition according
- dimethylsuccinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- YJEJKUQEXFSVCJ-WRFMNRASSA-N bevirimat Chemical compound C1C[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C YJEJKUQEXFSVCJ-WRFMNRASSA-N 0.000 claims 4
- 239000002552 dosage form Substances 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical class CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- 239000003125 aqueous solvent Substances 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims 2
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 239000002955 immunomodulating agent Substances 0.000 claims 1
- 229940121354 immunomodulator Drugs 0.000 claims 1
- 230000002584 immunomodulator Effects 0.000 claims 1
- 239000008297 liquid dosage form Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000006186 oral dosage form Substances 0.000 claims 1
- 239000006201 parenteral dosage form Substances 0.000 claims 1
- 239000006215 rectal suppository Substances 0.000 claims 1
- 229940100618 rectal suppository Drugs 0.000 claims 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55355404P | 2004-03-17 | 2004-03-17 | |
| US58467404P | 2004-07-02 | 2004-07-02 | |
| PCT/US2005/008935 WO2005090380A1 (en) | 2004-03-17 | 2005-03-17 | Pharmaceuticals salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007529544A JP2007529544A (ja) | 2007-10-25 |
| JP2007529544A5 true JP2007529544A5 (cg-RX-API-DMAC7.html) | 2008-05-08 |
Family
ID=34993638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007504115A Pending JP2007529544A (ja) | 2004-03-17 | 2005-03-17 | 3−o−(3’,3’−ジメチルスクシニル)ベツリン酸の製薬的な塩 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20050239748A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1730163A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007529544A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005224260A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0508854A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2560266A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL178128A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06010592A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20064676L (cg-RX-API-DMAC7.html) |
| RU (1) | RU2387665C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005090380A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0610668A2 (pt) * | 2005-04-12 | 2010-07-13 | Panacos Pharmaceuticals Inc | polimorfas de di-n-metil-d-glucamina do ácido 3-o-(3',3'-dimetilsuccinil) betulìnico |
| ZA200805703B (en) * | 2005-12-16 | 2009-10-28 | Panacos Pharmaceuticals Inc | Preparation of pharmaceutical salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid |
| US20080039428A1 (en) * | 2006-06-29 | 2008-02-14 | Panacos Pharmaceuticals, Inc. | Antiretroviral combination therapy |
| CZ300722B6 (cs) * | 2006-09-27 | 2009-07-22 | Univerzita Karlova v Praze, Prírodovedecká fakulta | Zpusob prípravy inkluzního komplexu pentacyklických a tetracyklických terpenoidu a farmaceutického prostredku obsahujícího tento inkluzní komplex, inkluzní komplex pentacyklického nebo tetracyklického terpenoidu a farmaceutický prostredek obsahující |
| WO2008057420A2 (en) | 2006-11-03 | 2008-05-15 | Panacos Pharmaceuticals, Inc. | Extended triterpene derivatives |
| WO2008091532A1 (en) * | 2007-01-19 | 2008-07-31 | Panacos Pharmaceuticals, Inc. | Salts of 3-o-(3',3'-dimethylsuccinyl)betulinic acid and solid state forms thereof |
| WO2012106190A1 (en) | 2011-01-31 | 2012-08-09 | Bristol-Myers Squibb Company | C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity |
| WO2009042166A1 (en) * | 2007-09-25 | 2009-04-02 | Panacos Pharmaceuticals, Inc. | Liquid bevirimat dosage forms for oral administration |
| JP2009120516A (ja) * | 2007-11-13 | 2009-06-04 | Tokyo Medical Univ | 抗ウィルス剤 |
| US8802727B2 (en) * | 2009-07-14 | 2014-08-12 | Hetero Research Foundation, Hetero Drugs Limited | Pharmaceutically acceptable salts of betulinic acid derivatives |
| US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
| CA2801487C (en) | 2010-06-04 | 2017-12-05 | Bristol-Myers Squibb Company | Modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
| BR112012030810A2 (pt) | 2010-06-04 | 2019-09-24 | Bristol-Myers Squibb Company | "c-28 amidas de derivados de ácido c-3 betulínico modificados como inibidores de maturação de hiv" |
| US20140221328A1 (en) * | 2011-01-10 | 2014-08-07 | Bandi Parthasaradhi Reddy | Pharmaceutically acceptable salts of novel betulinic acid derivatives |
| HRP20151212T1 (hr) | 2011-01-31 | 2015-12-04 | Bristol-Myers Squibb Company | C-28 AMINI C-3 MODIFICIRANIH DERIVATA BETULINSKE KISELINE KAO INHIBITORI SAZRIJEVANJA HIV-a P |
| RU2489147C2 (ru) * | 2011-08-31 | 2013-08-10 | Людмила Петровна Лазурина | Фармацевтическая антибактериальная композиция для местного применения на основе активных биометаллокомплексов |
| EP2758419B8 (en) | 2011-09-21 | 2017-04-19 | VIIV Healthcare UK (No.5) Limited | Novel betulinic acid derivatives with antiviral activity |
| US8906889B2 (en) | 2012-02-15 | 2014-12-09 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
| US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
| US9637516B2 (en) | 2012-12-31 | 2017-05-02 | Hetero Research Foundation | Betulinic acid proline derivatives as HIV inhibitors |
| EA027371B1 (ru) | 2013-02-06 | 2017-07-31 | Бристол-Майерс Сквибб Компани | C-19 модифицированные тритерпеноиды с ингибиторной активностью созревания вич |
| BR112015019590A2 (pt) | 2013-02-25 | 2017-07-18 | Bristol Myers Squibb Co | derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv |
| MX374543B (es) | 2014-04-11 | 2025-03-06 | Viiv Healthcare Uk No 4 Ltd | Triterpenoides con actividad inhibidora de la maduración del virus de inmunodeficiencia humana, sustituidos en la posición 3 con un anillo no aromático que lleva un sustituyente haloalquilo. |
| US9920090B2 (en) | 2014-06-19 | 2018-03-20 | VIIV Healthcare UK (No.5) Limited | Betulinic acid derivatives with HIV maturation inhibitory activity |
| US20170129916A1 (en) | 2014-06-26 | 2017-05-11 | Hetero Research Foundation | Novel betulinic proline imidazole derivatives as hiv inhibitors |
| RU2017118576A (ru) | 2014-11-14 | 2018-12-14 | ВАЙВ ХЕЛТКЕР ЮКей (N5) ЛИМИТЕД | C-17-арил-замещённые аналоги бетулиновой кислоты |
| AU2015346303B2 (en) | 2014-11-14 | 2018-03-15 | VIIV Healthcare UK (No.5) Limited | Oxolupene derivatives |
| MA40886B1 (fr) | 2015-02-09 | 2020-03-31 | Hetero Research Foundation | Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih |
| WO2016147099A2 (en) | 2015-03-16 | 2016-09-22 | Hetero Research Foundation | C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors |
| AR107512A1 (es) | 2016-02-04 | 2018-05-09 | VIIV HEALTHCARE UK Nº 5 LTD | Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1 |
| CN107638571B (zh) * | 2016-07-15 | 2021-07-06 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种特考韦瑞口服药物组合物及其制备方法 |
| CN107625967B (zh) | 2016-07-15 | 2021-07-06 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种特考韦瑞注射用药物组合物及其制备方法 |
| CN111417384A (zh) | 2017-09-14 | 2020-07-14 | 菲尼克斯生物技术公司 | 用于治疗神经系统病况的方法和改进的神经保护性组合物 |
| CA3075729A1 (en) | 2017-09-14 | 2019-03-21 | Phoenix Biotechnology, Inc. | Use of oleandrin to treatn viral infection |
| WO2020006510A1 (en) | 2018-06-29 | 2020-01-02 | Dfh Therapeutics | Triterpene amine derivatives |
| KR20220151038A (ko) | 2020-03-31 | 2022-11-11 | 피닉스 바이오테크놀러지 인코포레이티드. | 코로나바이러스 감염 예방를 위한 조성물 |
| EP4295854A3 (en) | 2020-03-31 | 2024-04-03 | Phoenix Biotechnology, Inc. | Method and compositions for treating coronavirus infection |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3839344A (en) * | 1973-03-28 | 1974-10-01 | Schering Corp | N-methyl d-glucamine salt of 2(2'-methyl-3'-trifluoromethylanilino)nicotinic acid |
| US4205073A (en) * | 1975-04-30 | 1980-05-27 | Schering Corporation | Anti-diarrheal anilino nicotinic acids and method of using same |
| US4377583A (en) * | 1981-08-21 | 1983-03-22 | Mead Johnson & Company | N-Methyl-D-glucamine salt of with 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-carboxylic acid |
| JPS60163897A (ja) * | 1984-02-06 | 1985-08-26 | Tokyo Tanabe Co Ltd | ウルソデオキシコ−ル酸メグルミン塩およびその注射剤 |
| US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| WO1993007904A1 (en) * | 1991-10-16 | 1993-04-29 | Schering Corporation | Lipophilic oligosaccharide antibiotic salt compositions |
| FR2683531B1 (fr) * | 1991-11-13 | 1993-12-31 | Rhone Poulenc Rorer Sa | Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent. |
| US5679828A (en) * | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
| GB9613455D0 (en) * | 1996-06-27 | 1996-08-28 | Aston Molecules Ltd | Analogues or derivatives of quercetin |
| US5776912A (en) * | 1996-12-20 | 1998-07-07 | Schering Corporation | Lipophilic oligosaccharide antibiotic compositions |
| US6043245A (en) * | 1997-09-25 | 2000-03-28 | Schering Corporation | Tetrahydrofuran antifungal phosphate |
| US6670345B1 (en) * | 1997-09-30 | 2003-12-30 | Dabur Research Foundation | Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid |
| NZ506623A (en) * | 1998-03-02 | 2002-10-25 | Univ North Carolina | Acylated betulin and dihydrobetulin derivatives, preparation thereof and use in treatment of retroviral infections |
| JP2002518521A (ja) * | 1998-06-20 | 2002-06-25 | ワシントン・ユニバーシティ | 医用画像解析、診断および治療のための膜透過性ペプチド錯体 |
| US6147077A (en) * | 1999-04-29 | 2000-11-14 | Sepracor Inc. | 2R,4S-hydroxyitraconazole isomers |
| US6579828B1 (en) * | 1999-10-15 | 2003-06-17 | Nippon Paper Industries Co. Ltd | Multi chromatic thermally sensitive recording medium |
| CA2406562C (en) * | 2000-05-08 | 2009-09-15 | Janssen Pharmaceutica N.V. | Hiv replication inhibiting pyrimidines and triazines |
| US7365221B2 (en) * | 2002-09-26 | 2008-04-29 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| AU2004210162A1 (en) * | 2003-01-29 | 2004-08-19 | Panacos Pharmaceuticals, Inc. | Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| EP1675866A1 (en) * | 2003-09-26 | 2006-07-05 | Panacos Pharmaceuticals, Inc. | Novel triterpene derivatives, preparation thereof and use thereof |
| RU2243233C1 (ru) * | 2003-12-24 | 2004-12-27 | Московская государственная академия тонкой химической технологии им. М.В. Ломоносова | Производные бетулина как ингибиторы комплемента |
-
2005
- 2005-03-17 EP EP05728826A patent/EP1730163A4/en not_active Withdrawn
- 2005-03-17 RU RU2006136409/04A patent/RU2387665C2/ru not_active IP Right Cessation
- 2005-03-17 CA CA002560266A patent/CA2560266A1/en not_active Abandoned
- 2005-03-17 WO PCT/US2005/008935 patent/WO2005090380A1/en not_active Ceased
- 2005-03-17 BR BRPI0508854-2A patent/BRPI0508854A/pt not_active IP Right Cessation
- 2005-03-17 JP JP2007504115A patent/JP2007529544A/ja active Pending
- 2005-03-17 AU AU2005224260A patent/AU2005224260A1/en not_active Abandoned
- 2005-03-17 US US11/081,802 patent/US20050239748A1/en not_active Abandoned
- 2005-03-17 MX MXPA06010592A patent/MXPA06010592A/es not_active Application Discontinuation
-
2006
- 2006-09-17 IL IL178128A patent/IL178128A0/en unknown
- 2006-10-16 NO NO20064676A patent/NO20064676L/no not_active Application Discontinuation
-
2012
- 2012-04-30 US US13/460,463 patent/US20120214775A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2006136409A (ru) | Фармацевтические соли 3-о-(3, 3-диметилсукцинил)бетулиновой кислоты | |
| Wang et al. | Turning the tide: Natural products and natural-product-inspired chemicals as potential counters to SARS-CoV-2 infection | |
| JP2009535352A5 (cg-RX-API-DMAC7.html) | ||
| JP2020097577A5 (cg-RX-API-DMAC7.html) | ||
| RU2325389C2 (ru) | Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью | |
| JP2007524683A5 (cg-RX-API-DMAC7.html) | ||
| Huang et al. | Antiviral biomaterials | |
| JP2010532372A5 (cg-RX-API-DMAC7.html) | ||
| ME02321B (me) | Antivirusna jedinjenja | |
| ATE378332T1 (de) | Benzofuranderivate,verfahren zu deren herstellung und zwischenprodukte davon | |
| JP2017515840A5 (cg-RX-API-DMAC7.html) | ||
| CA3151327A1 (en) | Benzimidazoles and methods of using same | |
| JP2008513510A5 (cg-RX-API-DMAC7.html) | ||
| JP2010520174A5 (cg-RX-API-DMAC7.html) | ||
| JP2006511538A5 (cg-RX-API-DMAC7.html) | ||
| PL1905427T3 (pl) | Szybko rozpuszczająca się formulacja niesteroidowych leków przeciwzapalnych | |
| IL192190A0 (en) | Process for the preparation of pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid | |
| JP2006507295A5 (cg-RX-API-DMAC7.html) | ||
| CN101190912A (zh) | 新的抗病毒化合物及其制备方法 | |
| RU2008151945A (ru) | Лекарственные формы с пульсирующим высвобождением и фармацевтические композиции фенилэфрина | |
| ATE455117T1 (de) | 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren | |
| WO2004043402A3 (en) | Modified nucleosides as antiviral agents | |
| CN102512387B (zh) | 扎西他滨药物组合物 | |
| CN103417977A (zh) | 叶酸受体α亚型高效介导的靶向投药系统 | |
| CA2931971A1 (en) | Amorphous cobicistat solid dispersion |